B
Bruno Lioure
Researcher at Curie Institute
Publications - 156
Citations - 6103
Bruno Lioure is an academic researcher from Curie Institute. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 36, co-authored 143 publications receiving 5525 citations.
Papers
More filters
Journal ArticleDOI
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
Arnaud Jaccard,Philippe Moreau,Véronique Leblond,Xavier Leleu,Lofti Benboubker,Olivier Hermine,Christian Recher,Bouchra Asli,Bruno Lioure,Bruno Royer,Fabrice Jardin,Franck Bridoux,Bernard Grosbois,Jérôme Jaubert,Jean-Charles Piette,Pierre Ronco,Fabrice Quet,Michel Cogné,Jean-Paul Fermand +18 more
TL;DR: The outcome of treatment of AL amyloidosis with high-doseMelphalan plus autologous stem-cell rescue was not superior to the outcome with standard-dose melphalanplus dexamethasone.
Journal ArticleDOI
Comparison of Autologous Bone Marrow Transplantation and Intensive Chemotherapy as Postremission Therapy in Adult Acute Myeloid Leukemia
Jean-Luc Harousseau,Jean-Yves Cahn,Bernard Pignon,Francis Witz,Noel Milpied,Martine Delain,Bruno Lioure,Thierry Lamy,Bernard Desablens,François Guilhot,Denis Caillot,JF Abgrall,Sylvie François,Jean Briere,Denis Guyotat,Philippe Casassus,Bruno Audhuy,Zéra Tellier,Patrick Hurteloup,Patrick Hervé +19 more
TL;DR: Three intensive consolidation strategies are currently proposed to younger adults with acute myeloid leukemia (AML) in first complete remission (CR): allogeneic or autologous bone marrow transplantation (BMT) and intensive consolidation chemotherapy (ICC).
Journal ArticleDOI
Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis
Yasmine Nivoix,Michel Velten,Valérie Letscher-Bru,Alireza Moghaddam,Shanti Natarajan-Amé,Cécile Fohrer,Bruno Lioure,Karin Bilger,Philippe Lutun,Luc Marcellin,Anne Launoy,Guy Freys,Jean-Pierre Bergerat,Raoul Herbrecht +13 more
TL;DR: Kohno et al. as discussed by the authors retrospectively reviewed 385 cases of suspected or documented aspergillosis that occurred during a 9-year period and identified 289 episodes that fulfilled the criteria for possible, probable, or proven invasive Aspergillus active antifungal drug treatment.
Journal ArticleDOI
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial
Dick J. van Rhenen,Hans Gulliksson,Jean-Pierre Cazenave,Derwood Pamphilon,Per Ljungman,Harald Klüter,Hans Vermeij,M. C. Kappers-Klunne,Georgine E. de Greef,M. Laforet,Bruno Lioure,Kathryn B. Davis,Stephane Marblie,Veronique Mayaudon,Jocelyne Flament,Maureen G. Conlan,Lily Lin,Peyton S. Metzel,Don Buchholz,Laurence Corash +19 more
TL;DR: Platelet components prepared with PCT offer the potential to further improve the safety of platelet transfusion using technology compatible with current methods to prepare buffy coat platelet components.
Journal ArticleDOI
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
Eric Jourdan,Nicolas Boissel,Sylvie Chevret,Eric Delabesse,Aline Renneville,Pascale Cornillet,Odile Blanchet,Jean-Michel Cayuela,Christian Recher,Emmanuel Raffoux,Jacques Delaunay,Arnaud Pigneux,Claude-Eric Bulabois,Céline Berthon,Cécile Pautas,Norbert Vey,Bruno Lioure,Xavier Thomas,Isabelle Luquet,Christine Terré,Philippe Guardiola,Marie C. Béné,Claude Preudhomme,Norbert Ifrah,Hervé Dombret +24 more
TL;DR: It is suggested that MRD, rather than gene mutations, should be used for future treatment stratifications in CBF-AML patients, as the sole prognostic factor in multivariate analysis.